Although aspirin and feniconazole nitrate are not common in the treatment of NAFLD, their pharmacological mechanisms involve the PPAR pathway, showing crucial function in regulating inflammation, insulin resistance, abnormal fat metabolism and others. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatotic liver disease.